Hepatitis C virus and HIV coinfection

Area of Science:

• Virology and Epidemiology
• Infectious Diseases
• Public Health

Background:

• Hepatitis C virus (HCV) affects approximately 1% of the global population.
• HCV is primarily a blood-borne virus, with major risk factors including blood product transfusion and intravenous drug use.
• Coinfection with human immunodeficiency virus (HIV) is common among HCV-infected individuals.

Purpose of the Study:

• To describe the epidemiology and clinical manifestations of HCV.
• To review the evidence regarding the impact of HCV/HIV coinfection on the progression of both viruses.
• To inform the management strategies for coinfected individuals.

Main Methods:

• Literature review of epidemiological data on HCV prevalence and risk factors.
• Analysis of clinical studies investigating the effects of HCV/HIV coinfection.
• Synthesis of evidence on viral progression in coinfected versus monoinfected individuals.

Main Results:

• The review details the global epidemiology and clinical presentation of HCV.
• It explores the significant overlap between HCV and HIV infections.
• The impact of coinfection on the progression of both HIV and HCV is considered.

Conclusions:

• Understanding the interplay between HCV and HIV is crucial for managing coinfected patients.
• Coinfection can significantly influence the morbidity and mortality associated with both viral infections.
• Further research and tailored clinical approaches are needed for effective coinfection management.